HBsAg LOSS IN CHRONIC HEPATITIS B PATIENTS AFTER 24-WEEK TREATMENT WITH SUBCUTANEOUSLY ADMINISTERED PD-L1 ANTIBODY ASC22 (ENVAFOLIMAB): INTERIM RESULTS FROM A PHASE IIb EXTENSION COHORT

Guiqiang Wang,Yimin Cui,Guoxin Hu,Lei Fu,Jiajie Lu,Yong-Ping Chen,Qing Xie,Yao Xie,Guizhou Zou,Xiaolin Guo,Jinlin Hou,Yongfeng Yang,Mao Qianguo,Handan He,Yuemei Yan, Jinzi Jason Wu

HEPATOLOGY（2024）

引用 0|浏览13

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要